您的当前位置:首页 > 行业数据 > 国内获批上市的促血小板生成药物
图片属性
图片格式:PNG 图片大小:188KB 图片尺寸:2302*913
同报告图片
 / 4
国内获批上市的促血小板生成药物_第1页
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
国内获批上市的促血小板生成药物_第2页
国内获批上市的促血小板生成药物_第3页
国内获批上市的促血小板生成药物_第4页
国内获批上市的促血小板生成药物_第5页
所属报告: 三生制药-港股公司研究报告-核心品种稳健增长创新管线迈入收获期-250217(35页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠